Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Inovio Pharmaceuticals (NASDAQ:INO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Inovio Pharmaceuticals missed estimated earnings by 48.39%, reporting an EPS of $-0.46 versus an estimate of $-0.31.
Revenue was up $511 thousand from the same period last year.
Last quarter the company missed on EPS by $0.02 which was followed by a 27.31% drop in the share price the next day.
Here's a look at Inovio Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.34 | -0.32 | -0.33 | -0.25 |
EPS Actual | -0.36 | -0.50 | -0.29 | -0.39 |
Revenue Estimate | 670K | 2.84M | 970K | 1.21M |
Revenue Actual | 199K | 839K | 291K | 272K |
To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: INO